Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 1995

Primary Completion Date

December 13, 2010

Study Completion Date

December 13, 2010

Conditions

Chronic Granulomatous DiseaseCommunicable Disease

Interventions

DRUG

Gene Therapy Method for CGD

DEVICE

Isolex 300i Magnetic Cell Selector

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001476 - Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up | Biotech Hunter | Biotech Hunter